Search Within

Ethan Martin Basch

Formats
  1. Journal Article (115)
  2. Meeting Abstract (61)
  3. Book Section (1)
  4. Book Whole (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (68)
  2. Solid Tumor Oncology Division (68)
  3. Population Sciences Research Program (67)
  4. Epidemiology and Biostatistics (41)
  5. Psychiatry and Behavioral Sciences, Department of (39)
  6. Genitourinary Oncology Service (36)

More Groups

People
  1. Lauren Rogak (38)
  2. Howard Scher (31)
  3. Thomas Atkinson (31)
  4. Laura Sit (21)
  5. Deborah Schrag (18)
  6. Mark Kris (18)

More People

Years
  1. 2022 (3)
  2. 2021 (2)
  3. 2020 (4)
  4. 2019 (4)
  5. 2018 (4)
  6. 2017 (5)

More Years

Publications
  1. Journal of Clinical Oncology (55)
  2. Journal of Herbal Pharmacotherapy (8)
  3. Quality of Life Research (7)
  4. Value in Health (7)
  5. International Journal of Radiation Oncology, Biology, Physics (6)
  6. Journal of Dietary Supplements (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (62)
  2. Elsevier Inc. (18)
  3. Elsevier Science, Inc. (12)
  4. Oxford University Press (12)
  5. Springer (10)
  6. Haworth Press Inc (8)

More Publishers

Results (180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized controlled trial of routine financial toxicity screening via electronic patient-reported outcomes (AFT-39)
    Meeting Abstract

    Blinder, V. S.; Deal, A. M.; Ginos, B. F.; Jansen, J.; Dueck, A. C.; Mazza, G. L.; Henson, S.; Carr, P. M.; Rogak, L. J.; Weiss, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
    Journal Article

    Mazza, G. L.; Petersen, M. M.; Ginos, B.; Langlais, B. T.; Heon, N.; Gounder, M. M.; Mahoney, M. R.; Zoroufy, A. J.; Schwartz, G. K.; Rogak, L. J.; more...
    Quality of Life Research (2022)

    Fulltext@MSK | Save
  • Evaluating treatment tolerability using the toxicity index with patient-reported outcomes data
    Journal Article

    Langlais, B.; Mazza, G. L.; Thanarajasingam, G.; Rogak, L. J.; Ginos, B.; Heon, N.; Scher, H. I.; Schwab, G.; Ganz, P. A.; Basch, E.; more...
    Journal of Pain and Symptom Management (2022)

    Fulltext@MSK | Save
  • A phase II, nonrandomized open trial assessing pain efficacy with radium-223 in symptomatic metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Tagawa, S.; Moryl, N.; Milowsky, M.; Heller, G.; Osborne, J.; Rathkopf, D.; Basch, E.; Pandit-Taskar, N.; Morris, M. J.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Journal Article

    Basch, E.; Becker, C.; Rogak, L. J.; Schrag, D.; Reeve, B. B.; Spears, P.; Smith, M. L.; Gounder, M. M.; Mahoney, M. R.; Schwartz, G. K.; more...
    Clinical Trials (2021)

    Fulltext@MSK | Save
  • Decision aids for localized prostate cancer: Initial outcomes from NCI Community Oncology Research Program Alliance Research Base Cancer Care Delivery Research (CCDR) Protocol-A191402CD: A cluster-randomized trial
    Meeting Abstract

    Tilburt, J. C.; Pacyna, J. E.; Petereit, D. G.; Kaur, J. S.; Rapkin, B. D.; Grubb, R.; Chang, G. J.; Morris, M. J.; Kovac, E.; Sloan, J. A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Randomized phase III trial of eribulin (E) versus standard weekly paclitaxel (P) as first- or second-line therapy for locally recurrent or metastatic breast cancer (MBC)
    Meeting Abstract

    Liu, M. C.; Hillman, D. W.; Frith, A. E.; Lyss, A. P.; Weckstein, D. J.; Moreno-Aspitia, A.; Le-Lindqwister, N.; Isaacs, C.; Wender, D. B.; Lewis, D. A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Composite grading algorithm for National Cancer Institute's PRO-CTCAE
    Meeting Abstract

    Dueck, A. C.; Becker, C. C.; Rogak, L. J.; Schrag, D.; Reeve, B.; Spears, P.; Smith, M. L.; Gounder, M. M.; Mahoney, M. R.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinician vs patient reporting of baseline and postbaseline symptoms for adverse event assessment in cancer clinical trials
    Research Letter

    Atkinson, T. M.; Dueck, A. C.; Satele, D. V.; Thanarajasingam, G.; Lafky, J. M.; Sloan, J. A.; Basch, E.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials
    Editorial

    Basch, E.; Leahy, A. B.
    Clinical Trials (2019)

    Fulltext@MSK | Save